<?xml version='1.0' encoding='utf-8'?>
<document id="25902733"><sentence text="Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy." /><sentence text="To describe potential drug-drug interactions in the area of HIV/hepatitis C virus (HCV) coinfection and injection drug use, including those between antiretrovirals (ARVs), direct-acting antivirals (DAAs), and opioid-agonist therapy, and to supply a practical approach to their management"><entity charOffset="209-215" id="DDI-PubMed.25902733.s2.e0" text="opioid" /></sentence><sentence text="" /><sentence text="We searched PubMed for relevant articles published up until February 2015 as well as conference reports and drug-drug-interaction Web sites" /><sentence text="" /><sentence text="We used the following search terms: pharmacokinetic and pharmacodynamic drug-drug interaction, opioid substitution, HIV, hepatitis and the individual names of the relevant agents of the following drug classes and the drug classes itself: reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, protease inhibitors, direct-acting antivirals, opioide, benzodiazepines, anticonvulsants, antidepressants and antipsychotics"><entity charOffset="367-374" id="DDI-PubMed.25902733.s6.e0" text="opioide" /><entity charOffset="376-391" id="DDI-PubMed.25902733.s6.e1" text="benzodiazepines" /><pair ddi="false" e1="DDI-PubMed.25902733.s6.e0" e2="DDI-PubMed.25902733.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25902733.s6.e0" e2="DDI-PubMed.25902733.s6.e1" /></sentence><sentence text=" Additional references were identified from a review of literature citations and drug-drug interaction Web sites" /><sentence text=" In our evaluation, we included German- and English-language studies and reports addressing drug-drug interactions between opioid agonist therapy and ARVs or DAAs"><entity charOffset="123-129" id="DDI-PubMed.25902733.s8.e0" text="opioid" /></sentence><sentence text="" /><sentence text="Pharmacokinetic data were available for all ARVs and DAAs except rilpivirine, indinavir, saquinavir, maraviroc, dolutegravir, and MK-8742 with buprenorphine as well as maraviroc with methadone Drug-drug interactions of potential clinical relevance are most likely to occur between opioid-replacement therapy and ARVs, particularly the nonnucleoside reverse transcriptase inhibitors, efavirenz and nevirapine, and HIV protease inhibitors"><entity charOffset="65-76" id="DDI-PubMed.25902733.s10.e0" text="rilpivirine" /><entity charOffset="78-87" id="DDI-PubMed.25902733.s10.e1" text="indinavir" /><entity charOffset="89-99" id="DDI-PubMed.25902733.s10.e2" text="saquinavir" /><entity charOffset="101-110" id="DDI-PubMed.25902733.s10.e3" text="maraviroc" /><entity charOffset="112-124" id="DDI-PubMed.25902733.s10.e4" text="dolutegravir" /><entity charOffset="130-137" id="DDI-PubMed.25902733.s10.e5" text="MK-8742" /><entity charOffset="143-156" id="DDI-PubMed.25902733.s10.e6" text="buprenorphine" /><entity charOffset="168-177" id="DDI-PubMed.25902733.s10.e7" text="maraviroc" /><entity charOffset="183-192" id="DDI-PubMed.25902733.s10.e8" text="methadone" /><entity charOffset="383-392" id="DDI-PubMed.25902733.s10.e9" text="efavirenz" /><entity charOffset="397-407" id="DDI-PubMed.25902733.s10.e10" text="nevirapine" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e0" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e1" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e2" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e3" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e4" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e5" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e0" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e1" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e2" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e3" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e4" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e5" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e1" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e2" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e3" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e4" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e5" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e2" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e3" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e4" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e5" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e3" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e4" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e5" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e4" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e5" e2="DDI-PubMed.25902733.s10.e5" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e5" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e5" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e5" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e5" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e5" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e6" e2="DDI-PubMed.25902733.s10.e6" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e6" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e6" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e6" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e6" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e7" e2="DDI-PubMed.25902733.s10.e7" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e7" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e7" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e7" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e8" e2="DDI-PubMed.25902733.s10.e8" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e8" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e8" e2="DDI-PubMed.25902733.s10.e10" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e9" e2="DDI-PubMed.25902733.s10.e9" /><pair ddi="false" e1="DDI-PubMed.25902733.s10.e9" e2="DDI-PubMed.25902733.s10.e10" /></sentence><sentence text="" /><sentence text="Integrase inhibitors may be safely coadministered with opioid-replacement therapy"><entity charOffset="55-61" id="DDI-PubMed.25902733.s12.e0" text="opioid" /></sentence><sentence text=" With respect to HCV DAAs, most currently approved and late-stage investigational agents do not have clinically significant interactions with opioid-replacement therapy"><entity charOffset="142-148" id="DDI-PubMed.25902733.s13.e0" text="opioid" /></sentence><sentence text=" ARV and DAAs may interact with other drug classes commonly used in the opioid-dependent population, including benzodiazepines, antidepressants, anticonvulsants, and antipsychotics"><entity charOffset="72-78" id="DDI-PubMed.25902733.s14.e0" text="opioid" /><entity charOffset="111-126" id="DDI-PubMed.25902733.s14.e1" text="benzodiazepines" /><pair ddi="false" e1="DDI-PubMed.25902733.s14.e0" e2="DDI-PubMed.25902733.s14.e0" /><pair ddi="false" e1="DDI-PubMed.25902733.s14.e0" e2="DDI-PubMed.25902733.s14.e1" /></sentence><sentence text="" /></document>